No Data
No Data
RAINMED-B: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2023
Rundeid-B (02297) released its interim performance, with a shareholder's loss of 41.646 million yuan, a year-on-year narrowing of 12.29%.
Runmaid-B (02297) released its interim performance for the six months ended June 30, 2024, during which the group achieved...
Express News | Rainmed Medical H1 Gross Profit RMB 18.7 Million
RAINMED-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
Rainmed Medical CFO Steps Down; Shares Drop 7%
Runmed-B announced that Huo Yunlong has been appointed as a non-executive director.
Runmai-B (02297) announced that, effective from August 26, 2024, Mr. Zhang Liang has resigned as an executive director, chief financial officer, and authorized representative of the company due to his intention to fulfill other commitments and to devote more time to his family. After Mr. Zhang's resignation from the positions of executive director, chief financial officer, and authorized representative, he will remain as the co-company secretary. Dr. Huo Yunlong has been appointed as a non-executive director. Mr. Huo Yunfei, the chairman of the board of directors and chief executive officer, has been appointed as the authorized representative.
No Data
No Data